DEVELOPMENT AND IN VITRO ASSESSMENT OF BUSPIRONE LOADED IN SITU NANOEMULSION GEL

Authors

  • KAMALESH TRIPATHI SHEAT College of Pharmacy, Varanasi, Uttar Pradesh, India
  • NIRANJAN KUMAR MANNA Faculty of Pharmacy, CSM Group of Institutions, Allahabad, Uttar Pradesh, India

DOI:

https://doi.org/10.22159/ijap.2021v13i4.41694

Keywords:

Nanoemulsion, Buspirone, In situ gel, Intranasal, Brain delivery, Phase diagram

Abstract

Objective: Buspirone, is a medication primarily used for generalized anxiety disorder (GAD), relieve symptoms of anxiety and unipolar depression. This drug exhibit low bioavailability (approximately 5%) due to extensive first-pass metabolism and non-targeted delivery results in numerous side effects. It is taken by mouth, and it may take up to four weeks to have an effect. The present investigation aimed at the development of buspirone in situ nanoemulsion gel to evaluate its potential for efficacious nose to brain drug delivery.

Methods: Buspirone-loaded nanoemulsions (BNEs) were prepared by aqueous titration (Spontaneous emulsification) method using Oleic acid, Tween 80, and PEG 400 as oil, surfactant and cosurfactant respectively. The NEs (FC1-FC8) were characterized for pharmaceutical characteristics (Appearance, thermodynamic stability, polydispersity index (PDI) value, globule size, pH, Viscosity, Conductivity and Refractive index). In vitro drug release study from nanoemulsions (NEs) was carried out using Keshary–Chien cell (KC cell, 25 ml) in phosphate buffer pH 5.5.

Results: Formulation FC5 with mean globule size of 105.4±1.10 nm, PDI value 0.230±0.01 and drug release 90±0.39% in 6 h (h) was developed as mucoadhesive nanoemulsion gel formulation with 17.5 % W/W of Pluronic F127. The nanoemulsion gel was homogenous, transparent, and possessed a bioadhesive strength of 1605 Dyne/cm2. In vitro cumulative drug release was found to be 90.00±0.39 % at the end of 6 h.

Conclusion: The gel had no effect on the structural integrity of nasal mucosa. Hence, the study postulates that In situ nanoemulsion gel of buspirone could be used as an intranasal formulation for targeted brain delivery via nasal route.

Downloads

Download data is not yet available.

References

Wu C, Li B, Zhang Y, Chen T, Chen C, Jiang W, et al. Intranasal delivery of paeoniflorin nanocrystals for brain targeting. Asian J Pharm Sci 2020;15:326–35.

Chattopadhyay S, Das S, Sarma KN. Nose-to-brain drug delivery : an update to the alternative path to successful targeted anti-migraine drugs. Int J Appl Pharm 2021;13:67-75.

Kim KT, Lee JY, Park JH, Kim MH, Kim JS, Shin HJ, et al. Development of HPLC method for the determination of buspirone in rat plasma using fluorescence detection and its application to a pharmacokinetic study. Chem Pharm Bull 2016;64:1582–8.

Najmul Hejaz Azmi S. Determination of buspirone HCl in commercial dosage forms by extractive spectrophotometric method and comparison by HPLC method. Sci J Anal Chem 2015;3:91-9.

Shah VA, Patel JK. Optmization and characterization of doxorubicin loaded solid lipid nanosuspension for nose to brain delivery using design expert software. Int J Pharm Pharm Sci 2021;13:45-57.

Ingrole RSJ, Gill HS. Special section on drug delivery technologies-minireview microneedle coating methods: a review with a perspective. J Pharmacol Exp Ther 2019;370:555–69.

Mittal D, Ali A, Md S, Baboota S, Sahni JK, Ali J. Insights into direct nose to brain delivery: current status and future perspective. Drug Delivery 2014;21:75–86.

Bonferoni MC, Rossi S, Sandri G, Ferrari F, Gavini E, Rassu G, et al. Nanoemulsions for “nose-to-brain” drug delivery. Pharmaceutics 2019;1:1–17.

Hamid KM, Wais M, Sawant G. A review on nanoemulsion formulation, composition and application. Asian J Pharm Clin Res 2021;14;22-8.

Shah J, Nair AB, Jacob S, Patel RK, Shah H, Shehata TM, et al. Nanoemulsion based vehicle for effective ocular delivery of moxifloxacin using experimental design and pharmacokinetic study in rabbits. Pharmaceutics 2019;11:1-16.

Chuo WH, LO YK, Huang YT, WU CS. Stastistical optimization and stability study of Quercetin loaded microemulsion. Int J Pharm Pharm Sci 2021;13:23-35.

Ding J, Li J, Mao S. Development and evaluation of vinpocetine inclusion complex for brain targeting. Asian J Pharm Sci 2015;10:114–20.

Shafiq S, Shakeel F, Talegaonkar S, Ahmad FJ, Khar RK, Ali M. Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur J Pharm Biopharm 2007;66:227–43.

Maraie NK, Almajidi YQ. Application of nanoemulsion technology for preparation and evaluation of intranasal mucoadhesive nano-in-situ gel for ondansetron HCL. J Glob Pharma Technol 2018;10:431–42.

Wik J, Bansal KK, Assmuth T, Rosling A, Rosenholm JM. Facile methodology of nanoemulsion preparation using oily polymer for the delivery of poorly soluble drugs. Drug Delivery Transl Res 2020;10:1228–40.

Harika K, Debnath S, Babu MN. Formulation and evaluation of nanoemulsion of amphotericin b. Int J Nov Trends Pharm Sci 2015;5:114–22.

Gaba B, Khan T, Haider MF, Alam T, Baboota S, Parvez S, et al. Vitamin E loaded naringenin nanoemulsion via intranasal delivery for the management of oxidative stress in a 6-OHDA Parkinson’s disease model. Biomed Res Int 2019;1-20. https://doi.org/10.1155/2019/2382563

Jamil L, Jan SU, Gul R. Formulation of microemulsion based gel of salbutamol sulfate and its in vitro studies. Int J Curr Pharm Res 2020;12:102-7.

Pengon S, Chinatangkul N, Limmatvapirat C, Limmatvapirat S. The effect of surfactant on the physical properties of coconut oil nanoemulsions. Asian J Pharm Sci 2018;13:409–14.

Mustafa IF, Hussein MZ. Synthesis and technology of nanoemulsion-based pesticide formulation. Nanomaterials 2020;10:1-26.

Sharma D, Maheshwari D, Philip G, Rana R, Bhatia S, Singh M, et al. Formulation and optimization of polymeric nanoparticles for intranasal delivery of lorazepam using box-behnken design: in vitro and in vivo evaluation. Biomed Res Int 2014;1-14. DOI:10.1155/2014/156010

Garala K, Joshi P, Patel J, Ramkishan A, Shah M. Formulation and evaluation of periodontal in situ gel. Int J Pharm Investig 2013;3:29-41.

Aderibigbe BA, Naki T. Chitosan-based nanocarriers for nose to brain delivery. Appl Sci 2019;9:1-27.

Kaur P, Garg T, Vaidya B, Prakash A, Rath G, Goyal AK. Brain delivery of intranasal in situ gel of nanoparticulated polymeric carriers containing antidepressant drug: behavioral and biochemical assessment. J Drug Target 2015;23:275–86.

Jaiswal M, Kumar M, Pathak K. Zero order delivery of itraconazole via polymeric micelles incorporated in situ ocular gel for the management of fungal keratitis. Colloids Surfaces B 2015;130:23–30.

Zeng L, Liu Y, Pan J, Liu X. Formulation and evaluation of norcanthridin nanoemulsions against the plutella xylostella (Lepidotera: Plutellidae). BMC Biotechnol 2019;19:1–11.

Patel RB, Patel MR, Bhatt KK, Patel BG, Gaikwad RV. Evaluation of brain targeting efficiency of intranasal microemulsion containing olanzapine: pharmacodynamic and pharmacokinetic consideration. Drug Delivery 2016;23:307–15.

Sudheer P. Design and evaluation of a self-emulsifying drug delivery system of aripiprazole. Int J Pharm Sci 2019;81:1089–98.

Xu M, Mou Y, Hu M, Dong W, Su X, Wu R, et al. Evaluation of micelles incorporated into thermosensitive hydrogels for intratumoral delivery and controlled release of docetaxel: a dual approach for in situ treatment of tumors. Asian J Pharm Sci 2018;13:373–82.

Sachan AK, Tripathi K, Sachan P, Gangwar SS. Fabrication and characterization of compressed solid dispersion based fast dissolving tablets of sildenafil citrate. Int J Pharm Sci Rev Res 2015;30:98-104.

Published

07-07-2021

How to Cite

TRIPATHI, K., & MANNA, N. K. (2021). DEVELOPMENT AND IN VITRO ASSESSMENT OF BUSPIRONE LOADED IN SITU NANOEMULSION GEL. International Journal of Applied Pharmaceutics, 13(4), 142–149. https://doi.org/10.22159/ijap.2021v13i4.41694

Issue

Section

Original Article(s)